Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 10
1971 3
1972 8
1973 36
1974 48
1975 71
1976 98
1977 87
1978 125
1979 108
1980 121
1981 127
1982 144
1983 119
1984 100
1985 124
1986 121
1987 116
1988 116
1989 118
1990 139
1991 103
1992 79
1993 95
1994 78
1995 78
1996 85
1997 59
1998 88
1999 84
2000 108
2001 83
2002 107
2003 106
2004 96
2005 130
2006 121
2007 132
2008 122
2009 119
2010 120
2011 141
2012 164
2013 191
2014 193
2015 187
2016 226
2017 221
2018 249
2019 278
2020 305
2021 312
2022 344
2023 283
2024 328
2025 445
2026 384

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,598 results

Results by year

Filters applied: . Clear all
Page 1
Cefazolin.
Quintiliani R, Nightingale CH. Quintiliani R, et al. Ann Intern Med. 1978 Nov;89(5 Pt 1):650-6. doi: 10.7326/0003-4819-89-5-650. Ann Intern Med. 1978. PMID: 362999 Clinical Trial.
After 5 years of use, cefazolin can be considered similar to cephalothin as a therapeutic agent and in its potential for adverse reactions. When cefazolin and cephalothin are compared by appropriately designed clinical trials, neither cefazolin's slightly gre …
After 5 years of use, cefazolin can be considered similar to cephalothin as a therapeutic agent and in its potential for adverse reac …
Cefazolin-induced neurotoxicity.
Ortiz A. Ortiz A. Clin Infect Dis. 1992 Feb;14(2):624. doi: 10.1093/clinids/14.2.624. Clin Infect Dis. 1992. PMID: 1554860 No abstract available.
[Cefazolin].
Yourassowsky E, Peromet M, Schoutens E. Yourassowsky E, et al. Acta Clin Belg. 1975;30(5):449-50. doi: 10.1080/17843286.1975.11717034. Acta Clin Belg. 1975. PMID: 1221750 French. No abstract available.
Cefazolin.
Griffith RS. Griffith RS. Adv Clin Pharmacol. 1974;8:123-7. Adv Clin Pharmacol. 1974. PMID: 4468727 No abstract available.
Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty.
Tran-Duy A, Asbury S, Spelman T, Paterson DL, Buising KL, McDougall C, Solomon M, Crawford R, Adie S, Molnar R, Mulford J, Harris-Brown T, Roney J, de Steiger R, Peel TN; ASAP Trial Group. Tran-Duy A, et al. Pharmacoeconomics. 2026 Jul;44(7):839-849. doi: 10.1007/s40273-026-01609-0. Epub 2026 Mar 13. Pharmacoeconomics. 2026. PMID: 41820715 Free PMC article. Clinical Trial.
We conducted an economic evaluation from the healthcare sector perspective to assess the cost-effectiveness of adding vancomycin to cefazolin prophylaxis in patients undergoing arthroplasty. METHODS: Data were collected over 180 days in a randomised controlled trial conduc …
We conducted an economic evaluation from the healthcare sector perspective to assess the cost-effectiveness of adding vancomycin to cefaz …
Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort.
Calderón-Parra J, Grillo S, Muñoz P, Machado-Vilchez M, Delgado-Montero A, De Alarcón-González A, Poyato-Borrego M, Goenaga-Sánchez MA, Fariñas-Alvarez MC, Miró JM, López-Cortés LE, Rodríguez-García R, Oteo JA, Martínez-Ramos A; Spanish Collaboration on Endocarditis (GAMES). Calderón-Parra J, et al. J Infect. 2024 Dec;89(6):106352. doi: 10.1016/j.jinf.2024.106352. Epub 2024 Nov 17. J Infect. 2024. PMID: 39561880 Free article.
OBJECTIVES: We aimed to evaluate the usefulness of antistaphylococcal penicillin (ASP) or cephazolin-based combinations versus monotherapy in patients with native-valve infective endocarditis (IE) caused by methicillin-susceptible Staphylococcus aureus (MSSA). ...We includ …
OBJECTIVES: We aimed to evaluate the usefulness of antistaphylococcal penicillin (ASP) or cephazolin-based combinations versus monoth …
Cefazolin Hypersensitivity: Toward Optimized Diagnosis.
Uyttebroek AP, Decuyper II, Bridts CH, Romano A, Hagendorens MM, Ebo DG, Sabato V. Uyttebroek AP, et al. J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1232-1236. doi: 10.1016/j.jaip.2016.05.011. Epub 2016 Jun 14. J Allergy Clin Immunol Pract. 2016. PMID: 27317018
BACKGROUND: Correct diagnosis of cefazolin hypersensitivity is not straightforward, mainly because of the absence of in vitro tests and uncertainties concerning the optimal cefazolin concentration for skin testing. ...A second part aimed at investigating the cross-r …
BACKGROUND: Correct diagnosis of cefazolin hypersensitivity is not straightforward, mainly because of the absence of in vitro tests a …
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Hu S, Lou Z, Shen Y, Tu M. Hu S, et al. Am J Trop Med Hyg. 2022 Sep 6;107(4):925-929. doi: 10.4269/ajtmh.21-1314. Print 2022 Oct 12. Am J Trop Med Hyg. 2022. PMID: 36067984 Free PMC article. Review.
According to the results of susceptibility testing, a majority of the isolates were resistant to some common first-line antibiotics, such as ampicillin, ampicillin/sulbactam, amoxicillin/clavulanic acid, cefoxitin, and cephazolin. Quinolones, however, have shown a better a …
According to the results of susceptibility testing, a majority of the isolates were resistant to some common first-line antibiotics, such as …
7,598 results